Drug Information

Drug General Information
Drug ID
D0Y9YN
Former ID
DNCL002771
Drug Name
Velimogene aliplasmid
Synonyms
Allovectin (TN)
Indication Melanoma [ICD9: 172; ICD10:C43] Phase 3 [521540]
Company
Vical
Target and Pathway
Target(s) HLA class I antigen B-7 Target Info Modulator [530830]
References
Ref 521540ClinicalTrials.gov (NCT00050388) Phase II Trial of Allovectin-7 for Head and Neck Cancer. U.S. National Institutes of Health.
Ref 530830Velimogene aliplasmid. Expert Opin Biol Ther. 2010 May;10(5):841-51.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.